• $122,121.00
    Market Cap
  • 0.00%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Income Statement
Total Operating Revenue
0
N/A
0
N/A
0
-100.00%
16.4M
N/A
Cost of Revenue
0
N/A
0
N/A
0
-100.00%
14.0M
N/A
Gross Profit
0
N/A
0
N/A
0
-100.00%
2.4M
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-261,550
-46.65%
-490,291
-40.30%
-821,321
+133.15%
-352,274
N/A
Depreciation and Amortization Expense
624
-98.99%
61,660
-12.52%
70,488
+48.86%
47,353
N/A
Total Operating Expenses
1.4M
-15.06%
1.7M
-10.51%
1.9M
-6.64%
2.0M
N/A
Operating Profit
-1.4M
-15.06%
-1.7M
-10.51%
-1.9M
-6.64%
-2.0M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-21,393
-88.03%
-178,652
-62.37%
-474,768
-63.07%
-1.3M
N/A
Interest Income and Expense and Net
-21,393
-88.03%
-178,652
-62.37%
-474,768
-63.07%
-1.3M
N/A
Total Nonoperating Income and Expense
58,832
+102.40%
-2.5M
-242.43%
1.7M
+229.37%
-1.3M
N/A
Income before Taxes
-1.4M
-66.99%
-4.1M
+2,715.29%
-146,528
-95.60%
-3.3M
N/A
Income Taxes
0
N/A
0
N/A
0
-100.00%
674,108
N/A
Extraordinary Items
3.0M
0.00%
3.0M
0.00%
3.0M
+572.52%
449,801
N/A
Net Income
-1.4M
-66.99%
-4.1M
+677.06%
-530,873
-85.75%
-3.7M
N/A
Net Income from Continuing Operations Applicable to Common
-1.6M
-60.24%
-4.1M
+677.06%
-530,873
-85.75%
-3.7M
N/A
Basic EPS and Net Income
0.00
+100.00%
-0.01
N/A
0.00
+100.00%
-0.01
N/A
Diluted EPS and Net Income
0.00
+100.00%
-0.01
N/A
0.00
+100.00%
-0.01
N/A
Basic Weighted Average Shares
396.7M
+10.90%
357.7M
+12.62%
317.6M
+11.37%
285.2M
N/A
Diluted Weighted Average Shares
396.7M
+10.90%
357.7M
+12.62%
317.6M
+11.37%
285.2M
N/A
Balance Sheet
Cash and Cash Equivalents
11,991
-89.09%
109,912
-53.01%
233,893
-70.51%
793,040
N/A
Short-Term Investments
0
N/A
0
N/A
0
N/A
0
N/A
Cash and Cash Equivalents and Short-Term Investments
11,991
-89.09%
109,912
-53.01%
233,893
-70.51%
793,040
N/A
Total Current Assets
103,442
-66.58%
309,504
-5.59%
327,826
-90.75%
3.5M
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
746,357
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
0
-100.00%
25,022
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
0
-100.00%
25,022
N/A
Total Assets
103,442
-70.64%
352,323
-86.18%
2.5M
-76.40%
10.8M
N/A
Income Taxes Payable
1.1M
+10.68%
958,455
+6.91%
896,495
+17.73%
761,509
N/A
Total Short-Term Debt
1.4M
+2.95%
1.4M
+41.37%
987,565
-73.64%
3.7M
N/A
Total Current Liabilities
5.1M
+7.06%
4.8M
+20.94%
3.9M
-54.23%
8.6M
N/A
Total Long-Term Debt
322,000
N/A
0
-100.00%
397,308
+35.87%
292,410
N/A
Total Long-Term Liabilities
203,186
+1.13%
200,921
+9.11%
184,142
-48.85%
360,008
N/A
Total Liabilities
5.4M
+13.82%
4.8M
+9.85%
4.3M
-64.72%
12.3M
N/A
Retained Earnings
-110.1M
+1.25%
-108.7M
+3.94%
-104.6M
+0.67%
-103.9M
N/A
Total Stockholders Equity
-5.3M
+20.57%
-4.4M
+147.21%
-1.8M
+20.96%
-1.5M
N/A
Total Shares Outstanding
406.1M
+6.34%
381.9M
+17.49%
325.0M
+3.08%
315.3M
N/A
Cash Flow
Cash from Operating Activities
-975,698
-36.10%
-1.5M
-18.18%
-1.9M
-14.60%
-2.2M
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
320,000
+1,111.06%
-31,650
-102.18%
1.5M
-68.85%
4.7M
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
557,777
-61.12%
1.4M
+389.26%
-495,925
-66.41%
-1.5M
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
14.69%
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
-12.17%
N/A
Return on Assets
-597.53%
+110.19%
-284.28%
+3,476.01%
-7.95%
-73.15%
-29.61%
N/A
Return on Equity
28.01%
-78.98%
133.28%
+308.82%
32.60%
-93.16%
476.83%
N/A
Revenue Growth
N/A
N/A
N/A
N/A
-100.00%
-123.43%
426.88%
N/A
Current Ratio
0.02
-68.77%
0.07
-21.97%
0.08
-79.79%
0.41
N/A
Cash Ratio
0.002
-89.61%
0.02
-61.11%
0.06
-35.57%
0.09
N/A
Debt-to-Equity Ratio
-0.33
+4.51%
-0.32
-59.22%
-0.78
-71.65%
-2.74
N/A
Debt-to-Assets Ratio
17.01
+329.22%
3.96
+629.61%
0.54
+45.29%
0.37
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow